These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 17868020)

  • 21. Medium term planning of biopharmaceutical manufacture using mathematical programming.
    Lakhdar K; Zhou Y; Savery J; Titchener-Hooker NJ; Papageorgiou LG
    Biotechnol Prog; 2005; 21(5):1478-89. PubMed ID: 16209554
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analytical method for promoting process capability of shock absorption steel.
    Sung WP; Shih MH; Chen KS
    J Zhejiang Univ Sci; 2003; 4(4):388-92. PubMed ID: 12861612
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of physiologically relevant biopharmaceutics tools within the pharmaceutical industry and in regulatory sciences: Where are we now and what are the gaps?
    Flanagan T; Van Peer A; Lindahl A
    Eur J Pharm Sci; 2016 Aug; 91():84-90. PubMed ID: 27283487
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fed-batch and perfusion culture processes: economic, environmental, and operational feasibility under uncertainty.
    Pollock J; Ho SV; Farid SS
    Biotechnol Bioeng; 2013 Jan; 110(1):206-19. PubMed ID: 22806692
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro methods to assess drug precipitation in the fasted small intestine - a PEARRL review.
    O'Dwyer PJ; Litou C; Box KJ; Dressman JB; Kostewicz ES; Kuentz M; Reppas C
    J Pharm Pharmacol; 2019 Apr; 71(4):536-556. PubMed ID: 29956338
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quality Control Testing for Tracking Endotoxin-Producing Gram-Negative Bacteria during the Preparation of Polyvalent Snake Antivenom Immunoglobulin.
    Sheraba NS; Diab MR; Yassin AS; Amin MA; Zedan HH
    PDA J Pharm Sci Technol; 2015; 69(4):499-510. PubMed ID: 26242786
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Implementation of Fully Integrated Continuous Antibody Processing: Effects on Productivity and COGm.
    Arnold L; Lee K; Rucker-Pezzini J; Lee JH
    Biotechnol J; 2019 Feb; 14(2):e1800061. PubMed ID: 29729129
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Purification of inclusion bodies using PEG precipitation under denaturing conditions to produce recombinant therapeutic proteins from Escherichia coli.
    Chen H; Li N; Xie Y; Jiang H; Yang X; Cagliero C; Shi S; Zhu C; Luo H; Chen J; Zhang L; Zhao M; Feng L; Lu H; Zhu J
    Appl Microbiol Biotechnol; 2017 Jul; 101(13):5267-5278. PubMed ID: 28391504
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antibodies and genetically engineered related molecules: production and purification.
    Roque AC; Lowe CR; Taipa MA
    Biotechnol Prog; 2004; 20(3):639-54. PubMed ID: 15176864
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Large scale demonstration of a process analytical technology application in bioprocessing: use of on-line high performance liquid chromatography for making real time pooling decisions for process chromatography.
    Rathore AS; Parr L; Dermawan S; Lawson K; Lu Y
    Biotechnol Prog; 2010; 26(2):448-57. PubMed ID: 19927320
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multiattribute selection of acute stroke imaging software platform for Extending the Time for Thrombolysis in Emergency Neurological Deficits (EXTEND) clinical trial.
    Churilov L; Liu D; Ma H; Christensen S; Nagakane Y; Campbell B; Parsons MW; Levi CR; Davis SM; Donnan GA
    Int J Stroke; 2013 Apr; 8(3):204-10. PubMed ID: 22812698
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development and evaluation of SOA-based AAL services in real-life environments: a case study and lessons learned.
    Stav E; Walderhaug S; Mikalsen M; Hanke S; Benc I
    Int J Med Inform; 2013 Nov; 82(11):e269-93. PubMed ID: 21481634
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A computer tool to support in design of industrial Ethernet.
    Lugli AB; Santos MM; Franco LR
    ISA Trans; 2009 Apr; 48(2):228-36. PubMed ID: 19215920
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regional intestinal drug permeation: biopharmaceutics and drug development.
    Lennernäs H
    Eur J Pharm Sci; 2014 Jun; 57():333-41. PubMed ID: 23988845
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Very rapid dissolution is not needed to guarantee bioequivalence for biopharmaceutics classification system (BCS) I drugs.
    Kortejärvi H; Shawahna R; Koski A; Malkki J; Ojala K; Yliperttula M
    J Pharm Sci; 2010 Feb; 99(2):621-5. PubMed ID: 19844950
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Discrete-event simulation models in the economic evaluation of health technologies and health products].
    Rodríguez Barrios JM; Serrano D; Monleón T; Caro J
    Gac Sanit; 2008; 22(2):151-61. PubMed ID: 18420015
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Proceedings of the 2017 Viral Clearance Symposium Session 5: Facility Risk Mitigation.
    Ma J; Kreil TR
    PDA J Pharm Sci Technol; 2018; 72(5):511-515. PubMed ID: 30030359
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An Integrated Approach of Fuzzy Linguistic Preference Based AHP and Fuzzy COPRAS for Machine Tool Evaluation.
    Nguyen HT; Md Dawal SZ; Nukman Y; Aoyama H; Case K
    PLoS One; 2015; 10(9):e0133599. PubMed ID: 26368541
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A framework for the prediction of scale-up when using compressible chromatographic packings.
    Tran R; Joseph JR; Sinclair A; Bracewell D; Zhou Y; Titchener-Hooker NJ
    Biotechnol Prog; 2007; 23(2):413-22. PubMed ID: 17302429
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Microfiltration membranes: characteristics and manufacturing.
    Reif OW
    Adv Biochem Eng Biotechnol; 2006; 98():73-103. PubMed ID: 16570862
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.